S860-119

Reported

BUST FENTANYL Act

119th Congress Introduced Mar 5, 2025

Summary

What This Bill Does

The reported BUST FENTANYL Act would expand the Fentanyl Sanctions Act to foreign persons determined to have knowingly engaged after enactment in significant activity or transactions materially contributing to opioid trafficking, as well as specified recipients of proceeds, significant supporters, controlled entities, and agents. It uses the existing sanctions menu rather than imposing a blanket trade ban on China or any other country. The President must prioritize identifying relevant persons from the People's Republic of China (PRC) supplying fentanyl, precursors, pre-precursors, or manufacturing equipment to Mexico or other countries producing fentanyl trafficked into the United States. The underlying report schedule is extended to December 31, 2030; the PRC priority continues until the required certification that China is no longer the primary source. The bill remains committee-reported, not enacted.

Who Benefits and How

U.S. communities exposed to illicit opioids may benefit if additional financial pressure and international cooperation disrupt trafficking, although the bill guarantees no reduction in drug supply or overdoses. The Department of State, Department of Justice, and congressional oversight committees gain more structured assessments of precursor controls, money laundering, diplomatic commitments and supply-chain shifts. The expanded mandatory sanctions framework applies to qualifying foreign private persons after the required presidential determinations; under the referenced law its minimum is five sanctions for entities and four for individuals, subject to applicable exceptions and waivers. A separate provision permits, but does not require, one or more sanctions against qualifying foreign-government subdivisions, agencies, instrumentalities and state-controlled financial institutions, and property-transaction sanctions against qualifying senior officials.

Who Bears the Burden and How

Foreign chemical and pharmaceutical businesses, financial institutions, intermediaries and other persons satisfying the statutory trafficking criteria face added sanctions exposure; lawful participation in those industries or PRC nationality alone does not establish a violation. U.S. financial institutions and other counterparties may need to screen and restrict transactions as sanctions are imposed. State and Justice must jointly produce an unclassified report with a classified annex and a classified briefing within 180 days, including assessments related to China and specified topics for India, Mexico and other important source countries. Treasury faces sanctions implementation work, and the President faces identification and certification duties. The bill reports on efforts to obtain Chinese approval for DEA offices in Shanghai and Guangzhou; it does not itself establish those offices. No new appropriation or broad import tariff is specified.

Key Provisions

  • Moves the annual International Narcotics Control Strategy Report deadline from March 1 to June 1 and broadens the methamphetamine-precursor language beyond named chemicals.
  • Requires State and Justice to report within 180 days on precursor controls, money laundering, international cooperation, commitments, supply-chain shifts, and next steps, with a separate classified briefing on DEA access and provincial partnerships.
  • Requires priority identification of relevant PRC individuals and entities involved in trafficking-related shipments, including pharmaceutical producers and their agents, and extends the statutory reporting endpoint to December 31, 2030.
  • Expands sanctions eligibility to significant knowing contributions, related proceeds, support networks, ownership/control relationships and agents; required presidential determinations remain.
  • Authorizes discretionary sanctions against qualifying foreign-government bodies and state-owned banks, with property-transaction restrictions available for qualifying senior officials.
  • Expands the annual methamphetamine report to identify significant source countries affecting the United States and describe their governments' precursor-diversion and trafficking-control efforts.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Broaden fentanyl-related sanctions eligibility and foreign-government sanctions authority, prioritize identification of relevant PRC suppliers, and expand narcotics diplomacy and reporting requirements.

Key Policy Areas

International narcotics control, Financial sanctions, Foreign relations, Public health

Primary Purpose

Broaden fentanyl-related sanctions eligibility and foreign-government sanctions authority, prioritize identification of relevant PRC suppliers, and expand narcotics diplomacy and reporting requirements.

Policy Domains

International narcotics control Financial sanctions Foreign relations Public health

BUST FENTANYL Act

Identified Gains
  • U.S. communities affected by illicit opioids
  • Congressional narcotics-control oversight committees
Model: codex-gpt-6-inline | Version: bill_summary_v2 | Source: rs
U.S. communities affected by illicit opioids: , , , , ,
Congressional narcotics-control oversight committees: , , , , ,
Identified Costs
  • Department of State
  • Department of Justice
  • Department of the Treasury
  • Foreign persons materially supporting opioid trafficking
  • Foreign government bodies supporting opioid trafficking
  • U.S. financial institutions
Model: codex-gpt-6-inline | Version: bill_summary_v2 | Source: rs
Department of State: , , , , ,
Department of Justice: , , , , ,
Department of the Treasury: , , , , ,
U.S. financial institutions: , , , , ,
Foreign government bodies supporting opioid trafficking: , , , , ,
Foreign persons materially supporting opioid trafficking: , , , , ,

Legislative Progress

Reported
Introduced Committee Passed
Apr 28, 2025

Reported by Mr. Risch, without amendment

Apr 28, 2025

Placed on Senate Legislative Calendar under General Orders. Calendar No. …

Apr 28, 2025

Committee on Foreign Relations. Reported by Senator Risch without amendment. …

Mar 27, 2025

Committee on Foreign Relations. Ordered to be reported without amendment …

Mar 5, 2025

Mr. Risch (for himself, Mrs. Shaheen, Mr. Hagerty, and Mr. …

Mar 5, 2025

Mr. Risch (for himself and Mrs. Shaheen) introduced the following …

Mar 5, 2025

Read twice and referred to the Committee on Foreign Relations.

Mar 5, 2025

Introduced in Senate

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
11 mentions across 6 clauses
+2 positive -9 negative

Department of Justice, Department of State, Department of the Treasury

Department of State, Department of the Treasury face effects in multiple directions

General Public
6 mentions across 5 clauses
+5 positive -1 negative

Foreign officials knowingly facilitating opioid trafficking, U.S. communities affected by illicit opioids, U.S. communities affected by methamphetamine trafficking

Positive-direction: U.S. communities affected by illicit opioids, U.S. communities affected by methamphetamine trafficking

Negative-direction: Foreign officials knowingly facilitating opioid trafficking

Financial Services
4 mentions across 2 clauses
+2 positive -2 negative

Foreign financial institutions materially supporting opioid trafficking, Foreign state-controlled banks materially supporting opioid trafficking, U.S. financial institutions

U.S. financial institutions faces effects in multiple directions

Positive-direction: Foreign financial institutions materially supporting opioid trafficking

Negative-direction: Foreign state-controlled banks materially supporting opioid trafficking

Manufacturing
3 mentions across 2 clauses
+1 positive -2 negative

Foreign chemical suppliers materially supporting opioid trafficking, PRC chemical suppliers involved in specified trafficking-related shipments, PRC pharmaceutical producers involved in specified trafficking-related shipments

Positive-direction: Foreign chemical suppliers materially supporting opioid trafficking

Negative-direction: PRC chemical suppliers involved in specified trafficking-related shipments, PRC pharmaceutical producers involved in specified trafficking-related shipments

Business
1 mention across 1 clause
+1 positive

Foreign recipients of opioid-trafficking proceeds

3/7
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
International narcotics control Financial sanctions Foreign relations Public health
Actor Mappings
"dea"
→ Drug Enforcement Administration
"prc"
→ People's Republic of China
"president"
→ President of the United States
"attorney_general"
→ Attorney General of the United States
"secretary_of_state"
→ Secretary of State

Key Definitions

Terms defined in this bill

3 terms
"Knowingly and opioid trafficking" §6-knowledge

Use the definitions in section 7203 of the Fentanyl Sanctions Act (21 U.S.C. 2302).

"Person of the People's Republic of China" §4-prc-person

A PRC citizen or national, or an entity organized under PRC law or otherwise subject to PRC government jurisdiction; trafficking-related shipment criteria govern the identification priority.

"Covered foreign-government body" §6-state-body

Political subdivision, agency or instrumentality of a foreign government, expressly including a government-owned or controlled financial institution, subject to the stated knowing-contribution/support determination.

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology